AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$18.71
+2.35%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $0.23
- Revenue estimate
- $812.9M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $0.30
- EPS estimate
- $0.22
- Revenue actual
- $796.2M
- Revenue estimate
- $768.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +41.3%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $23
- PT range
- $20 – $25
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $0.22 | $0.30 | Beat 34.83% | $796.2M |
| May 1, 2026 | $0.17 | $0.27 | Beat 58.82% | $722.5M |
| Oct 30, 2025 | $0.13 | $0.17 | Beat 30.77% | $784.5M |
| May 2, 2025 | $0.15 | $0.21 | Beat 40.94% | $695.4M |
| Feb 28, 2025 | $0.15 | $0.12 | Miss -20.00% | $730.5M |
| Nov 8, 2024 | $0.13 | $0.16 | Beat 23.08% | $702.5M |
| Aug 9, 2024 | $0.14 | $0.16 | Beat 14.29% | $701.8M |
| May 3, 2024 | $0.09 | $0.14 | Beat 55.56% | $659.2M |
| Mar 1, 2024 | $0.07 | $0.14 | Beat 100.00% | $617.0M |
| Aug 4, 2023 | $0.10 | $0.19 | Beat 90.00% | $599.0M |
| May 5, 2023 | $0.09 | $0.12 | Beat 33.33% | $557.5M |
| Mar 2, 2023 | $0.21 | $0.23 | Beat 9.52% | $609.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026